DePuy Synthes Receives FDA Clearance for TriALTIS Spine System and Navigated Instruments

DePuy Synthes secured FDA 510(k) clearances for the TriALTIS Spine System and for TriALTIS Navigation Enabled Instruments.

• The TriALTIS Spine System is a next-generation posterior thoracolumbar pedicle screw that offers a comprehensive implant portfolio and advanced instrumentation designed for integration with enabling technology.
• TriALTIS Navigation Enabled Instruments include drills, taps and screwdrivers that can be operated manually or under power for navigated and non-navigated use.

Combining a new portfolio of implants with a digital ecosystem, TriALTIS Spine aims to address unmet clinical needs and help surgeons achieve more consistent outcomes in treating complex spine conditions, inclusive of degenerative, tumor, trauma and deformity pathologies.

The TriALTIS Spine System was developed with a hyper-focus on performance and a consistent user experience. The inclusive design philosophy of the TriALTIS Spine System affords smooth integration with cement augmentation, power, navigation and robotic-assisted solutions.

Russell Powers, Worldwide President, Spine, DePuy Synthes said, “Johnson & Johnson MedTech is proud to deliver this exciting innovation that can help facilitate the surgical treatment of spinal degeneration and deformity with the goal to improve fixation, drive better patient outcomes and potentially reduce the clinical and economic burden associated with the current standard of care.”

Source: Johnson & Johnson

Save Supplier